Work

Clinically actionable UGT1A1 variants in black Zimbabwean cancer patients eligible for irinotecan

Year: 2025

Type: preprint

DOI: 10.12688/verixiv.2312.1

Authors: Rissy M. Wesonga, Tinashe A. Mazhindu, Zedias Chikwambi, Margaret Z. Borok, Ntokozo Ndlovu, Thomas M. Polasek, Collen Masimirembwa

Institutions: Chinhoyi University of Technology, African Institute of Biomedical Science and Technology, University of Zimbabwe, Monash University

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Bill and Melinda Gates Foundation, European and Developing Countries Clinical Trials Partnership

Awards: Pharmacogenomics Research And Clinical Excellence in the Treatment of Infectious Diseases in African Populations, African Institute of Biomedical Science And Technology - to support the development of extraordinary scientists and emerging leaders from low and middle income countries in order to ensure transformative ...

OpenAlex ID: W4415818672

Cites: 67

Cited by:

Related to: